Skip to main content
NCBI home page
ACS Omega logoLink to ACS Omega
. 2022 Oct 13;7(42):37112–37121. doi: 10.1021/acsomega.2c02938

Click Chemistry Inspired Synthesis of Hydroxyanthracene Triazolyl Glycoconjugates

Nishant Pandey †,‡, Pratibha Dwivedi †, Jyoti †,‡, Mangat Singh †,‡, Dhananjay Kumar ∥, Vinod K Tiwari §, Bhuwan B Mishra †,*
PMCID: PMC9608419  PMID: 36312433

Abstract

graphic file with name ao2c02938_0010.jpg

Novel hydroxyanthracene-based terminal alkynes 3 and 5a/b were synthesized by the acetylide addition reaction at the 9,10-position of anthraquinone 1 under mild conditions. The developed alkynes 3, 5a, and 5b on Huisgen azide-alkyne cycloaddition reaction with azido-sugars 6 in the presence of Cu(I) catalyst provided a series of triazole fasten hydroxyanthracene glycoconjugates 7, 8, and 9, respectively, in good yields. The representative compounds 9 and 7h were successfully deprotected under room-temperature conditions to liberate the corresponding free glycoconjugates 10 and 11, respectively. Further, structures of a few compounds were unmaliciously evidenced by their single-crystal X-ray.

1. Introduction

Anthranoids are a class of abundant anthracene derivatives, e.g., anthranol, anthrone, anthraquinone, etc., widely distributed in the plant kingdom.1,2 Many anthranoids, e.g., emodin, rhein, chrysophanol, physcion, etc., isolated from roots and barks of several plants, molds, and lichens have displayed some noticeable biological activities.3 They can be easily embedded in the DNA double helix and often exhibit potential antimalarial, antiplatelet, and neuroprotective properties.4,5 A diverse range of anthracyclines, e.g., idarubicin, daunorubicin, epirubicin, etc., have been already approved by the US FDA for the treatment of infectious (bacterial, fungal, and viral) and inflammatory diseases and oncology.6−10 Besides, many anthraquinones have profound applications as dyes in the textile and agrochemicals industries.

There has been increasing attention in the design and synthesis of novel anthraquinone glycosides with a belief that they may possess stronger laxative effects than the free aglycone.11 Numerous studies have established that the anthraquinone glycosides are very less likely to enter into the systemic circulation, hence, possess laxative effects even at lower doses in comparison to the corresponding aglycones. Therefore, there is interest in the development of new strategies that may offer a potentially more reliable route to the homogeneous glycoconjugates, leading to either the exact copies of naturally occurring glycosides or, alternatively, mimicking the glycosidic linkages found in nature.12 An appreciable benefit of the latter approach is that the artificial glycoconjugates may retain the geometric and special characteristic of native glycoform and exhibit hydrolytic stability toward glycosidases and glycosyltransferases.

Cu(I)-catalyzed azide–alkyne cycloaddition (CuAAC) has emerged as a straightforward molecular linking strategy to obtain products relevant to medicine, biology, and materials science.13,14 Earlier, several functionalized anthraquinone derivatives have been synthesized for a diverse range of applications, e.g., photoinitiators in polymerization, electo-chemical enhancers, chemo-sensor in metal ion sensing, colorimetric reagent for anions, enzyme inhibitors, etc.15,16 However, in all such compounds, the functionalization has been carried out exclusively at the benzene residues of the anthraquinone skeleton. There are no reports on “click” chemistry inspired functionalization at quinone-carbons (9,10-postion) of anthraquinone. Therefore, we herein report the synthesis of some terminal alkynes, such as, ethynyl-10-hydroxyanthracen-9-one 3, and diastereoisomeric compounds, cis/trans-diethynyl-9,10-dihydroanthracene-diols 5a/b, in good yields under the mild reaction conditions from commercially available anthraquinone 1 as a substrate. The CuAAC reaction of terminal alkynes 3, 5a, and 5b with diverse range of azido-sugars 6 furnished a series of regioselective glycoconjugates 7, 8, and 9 in 80–90% yields. We also investigated the deprotection of compounds 9 and 7h to afford the corresponding free glycoconjugates 10 and 11, respectively, in good yields. Click chemistry inspired functionalization at the 9,10-position of anthraquinone 1 has never been attempted; hence, the developed terminal alkynes 5a/b in addition to the triazolyl glycoconjugates 7–11 are new.

2. Results and Discussion

The strategy begins with the reaction of anthraquinone 1 with lithium (trimethysilyl)acetylide (2.0 equiv) in the presence of n-butyl lithium under an inert condition giving an acetylide addition product 2 in good yields (Scheme 1). The compound 2 after purification with silica gel (Flash) column chromatography (CC) was characterized using spectroscopic methods (UV, FT-IR, NMR, and HRMS). The unambiguous structure of 2 was evidenced by single-crystal X-ray diffraction analysis (see Supporting Information Table S2).

Scheme 1. Synthesis of Anthraquinone-Based Terminal Alkyne 3.

Scheme 1

Open in a new tab

Generally, the acetylide ion attacks a carbonyl group of compound 1 to produce an alkynol 2 (alcohol on carbon adjacent to triple bond) as a sole product. However, in the presence of an excess of lithium (trimethysilyl)acetylide, both the carbonyl groups in compound 1 undergo acetylide addition giving a mixture of cis/trans-4a/b with a high diastereoselectivity. The diastereoselectivity of the reaction was found to be solvent dependent, such as, the silylation of compound 1 in the presence of tetrahydrofuran (THF) resulted in the formation of a mixture of cis/trans-4a/b (1:9). However, a reverse diastereoselectivity in product formation was observed while carrying out the reaction in the presence of anhydrous toluene as a reaction solvent under an inert reaction condition (Scheme 2).17 Both the diastereomers were isolated successfully using silica gel (Flash) CC followed by characterization through UV, FT-IR, NMR, and HRMS analyses. Unambiguous structure of diastereomer 4a was evidenced by single-crystal X-ray diffraction analysis (see Supporting Information Figure S51 and Table S4).

Scheme 2. Synthesis of Terminal Alkynes 5a/b from Acetylide Addition Products 4a/b.

Scheme 2

Open in a new tab

The desilylation of TMS derivatives 2 and 4a/b was affected by treatment with methanolic KOH solution in the presence of THF to afford the corresponding terminal alkynes 3 and 5a/b, respectively, in good yields (Scheme 2). All the developed terminal alkynes 3, 5a, and 5b were isolated from reaction mixture via silica gel (Flash) CC. Their structures were deduced by FT-IR, NMR, and HRMS analyses. The unambiguous structure of compound 5a was evidenced by single-crystal X-ray analysis (see Supporting Information Figure S52 and Table S5).

The CuAAC reaction of alkynes 3 and 5a/b was carried out with numerous deoxy-azido-sugars 6 readily prepared from commercially available monosaccharides via application of protection and modification methods reported in literature (see Supporting Information Table S1).18,19 Generally, the CuAAC reaction is known to proceed in protic and aprotic solvents. They are well tolerated by most of the functional groups. Therefore, reaction of terminal alkyne 3 with azido-sugar 6a in the presence of DIPEA and CuI (catalytic amount) in dry dichloromethane (DCM) as reaction solvent under the inert atmosphere afforded 2-(4-(9-hydroxy-10-oxo-9,10-dihydroanthracen-9-yl)-1H-1,2,3-triazol-1-yl)-2,3,4-tri-O-acetyl-β-d-xylopyranose 7a in 90% yield. The reaction was completed smoothly in 12 h at room temperature (RT). The HR-MS spectrum of compound 7a exhibited a molecular ion peak [M + H]+ at m/z 536.1646 which corresponds to molecular formula C27H25N3O9. The 500 MHz 1H NMR spectrum of compound 7a exhibited resonances corresponding to 25 protons. A total of eight aromatic protons of the anthracene ring resonated as multiplet, two protons each observed between δ 8.06–8.01, δ 7.66–7.62, δ 7.46–7.44, and δ 7.43–7.41 ppm. The characteristic peak of the triazolyl-function resonated as a singlet at δ 7.39 ppm. The anomeric protons of sugar residue appeared as a multiplet between δ 5.72–5.68 ppm. The oxy-methylene group resonated as a multiplet observed between δ 5.37–4.11, while a broad one proton singlet at δ 3.52 was attributed to the presence of a hydroxyl group in the compound 7a. Signals for methyl hydrogens were observed at δ 2.05, δ 2.01, and δ 1.85 ppm. The unambiguous structure of compound 7a (Figure 1) was established by single-crystal X-ray analysis (see Supporting Information Table S6).

Figure 1.

Figure 1

Open in a new tab

Molecular structure of 7a: Thermal ellipsoids of C, N, and O set at 50% probability.

The methodology was further used successfully for the cycloaddition of other alkynes with azido-sugars to afford the libraries of 10-hydroxyanthracen-9(10H)-one linked triazolyl-glycoconjugates 7 (Table 1) and bis-triazolyl glycoconjugates 8 and 9 (Table 2). Although, the regioselective CuAAC reaction of terminal alkyne 5a(20−22) with azido-sugars 6 took a slightly longer time for completion. However, the yields of resulting bis-triazolyl derivatives 8 were found to be consistent, such as, the unreacted terminal alkynes 5a could not be detected in the product mixture. The structure of compounds 8 was deduced by NMR spectroscopy, wherein the 1H NMR spectrum of compounds 8 was observed clean and simple due to a relatively symmetric proton environment compared to the compound 9 that was obtained by CuAAC reaction of trans-alkyne 5b with the azido-sugar 6b.

Table 1. Synthesis of Triazolyl Glycoconjugates 7 via CuAAC Reaction.

2.

2.

Open in a new tab
a

Molar ratios: Compounds 3 (1.0 equiv) and 4 (1.3 equiv), CuI (0.5 equiv), and DIPEA (1.0 equiv) in anhydrous DCM at RT.

b

Triazolyl glycoconjugates.

c

Isolated yield at RT (time = 12 h).

Table 2. Synthesis of bis-Triazolyl Glycoconjugates 8 via CuAAC Reaction.

2.

2.

Open in a new tab
a

Reaction conditions: Compounds 5a (1.0 equiv) and 6 (3.0 equiv), CuI (1.0 equiv) and DIPEA (2.0 equiv) in anhydrous DCM at RT.

b

bis-Triazolyl glycoconjugates.

c

Isolated yield at RT.

In view of potential applications of the developed triazolyl glycoconjugates 7, 8, and 9 in future biological assays, we also investigated their deprotection reactions to obtain the corresponding free glycoconjugates. A representative acetyl-protected compound 9 could be deprotected successfully by reaction with sodium alkoxide to afford the corresponding free glycoconjugate 10 in good yield (Scheme 3).23 Similarly, the compounds bearing isopropylidene function could also be deprotected easily, such as a representative compound 7h on reaction with trifluoroacetic acid (TFA) in water as a medium resulted in the formation of corresponding free triazolyl glycoconjugate 11 (Scheme 4). The compound 11 could be isolated in good yields via silica gel (Flash) CC. The HR-MS spectrum of compound 11 exhibited a molecular ion peak [M + H]+ at m/z 440.1411 which corresponded to the molecular formula C22H21N3O7. The 1H NMR spectrum (500 MHz, DMSO-d6) of compound 11 exhibited resonances corresponding to 22 hydrogens. A doublet observed at δ 8.04 (J = 7.8 Hz) was assigned to the two aromatic protons, while the triazolyl-hydrogen appeared as singlet at δ 7.96 ppm. The compound 11 exhibited a total of three multiplets, two protons each observed between δ 7.75–7.43 for the corresponding six hydroxyanthracen-9(10H)-one nucleus. A singlet corresponding to the hydroxyl-group was observed at δ 6.94. The four hydroxyl protons of the sugar residue resonated as four multiplets appeared between δ 4.84–4.52 ppm. Two methylene protons adjacent to triazole ring resonated as multiplet between δ 4.33–4.27. The signal of tertiary hydrogens in sugar residue appeared as a multiplet between δ 4.14–3.45 ppm.

Scheme 3. Synthesis of bis-Triazolyl Glycoconjugates 9 and 10.

Scheme 3

Open in a new tab

Scheme 4. Deprotection of Isopropylidene-Protected Triazolyl Glycoconjugate.

Scheme 4

Open in a new tab

3. Conclusion

A diverse range of hydroxyl-anthracene-based terminal alkynes were prepared in good yields by the acetylide addition at the 9,10-position of anthraquinone via reaction with lithium(trimethysilyl)acetylide in the presence of n-butyl lithium under inert conditions. The CuAAC reaction of the developed terminal alkynes with deoxy-sugar azides resulted in the synthesis of a series of mono- and bis-triazolyl glycoconjugates in excellent yields. The representative compounds 9 and 7h were successfully deprotected to liberate the corresponding free triazolyl glycoconjugates 10 and 11, respectively, for application in future biological assays.

4. Experimental Section

4.1. General Information

Pure analytical grade reagents and solvents were used for syntheses. Experiments were performed in glassware dried in an oven at 100 °C. Reactions were monitored on silica gel 60 F254 aluminum TLC plates (Merck) and visualized under UV lamp or using spraying reagent (Draggendorff reagent, iodine vapors, or methanolic-H2SO4 solution) followed by charring at 100 °C. 1H (500 MHz) and 13C NMR (125 MHz) were recorded in CDCl3 or DMSO-d6 as solvents with chemical shift values given in δ (ppm) relative to trimethylsilyl (TMS). Data shown as chemical shift, integration, multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet) and coupling constants (Hz). High-resolution mass spectra (HR-MS) were obtained by ESI-TOF mode. IR spectra were obtained on a FT-IR Agilent Cary 660 series spectrometer. Single-crystal X-ray data of compounds were obtained from Super-Nova X-ray diffractometer with scan speed set at 5 s/scan, and data reduction was done by CrysAlisPro software. The melting point of compounds was determined on M565 Buchi melting apparatus.

4.2. Procedure for Synthesis of Trimethylsilylanthracen-9-one (2)

A three neck RB flask (250 mL) was charged with anhydrous toluene (100 mL) and trimethylsilyl acetylene (2.84 mL, 20 mmol). To the solution after purging with a positive pressure of argon for 30 min, n-butyllithium (2.5 M in hexane) (8.0 mL, 20 mmol) was added in a dropwise manner under argon pressure at 0 °C. The reaction mixture was allowed to attain RT under stirring for 45 min. Solid anthraquinone (2.08 g, 10 mmol) was added to the reaction mixture in one lot. The resulting mixture was stirred for 14 h at RT. After time elapsed, the reaction was further heated at 50–55 °C for a period of 36 h. After quenching with ammonium chloride solution under cooling and extraction with ethyl acetate, the organic phase was collected over dried Na2SO4. Concentration of organic layer under the reduced pressure afforded a brown solid which was chromatographed over silica gel (Flash) to afford compound 2 as a white crystalline solid in 80% yield.

4.2.1. 10-Hydroxy-10-((trimethylsilyl)ethynyl)anthracen-9(10H)-one (2)

White crystalline solid (2.5 g, 80% yield); mp = 147–152 °C; IR (KBr) vmax: 3383, 2919, 2855, 2338, 2257, 1728, 1640, 1588, 1451, 1368, 1316, 1254, 1167, 1036, 983, 925, 838, 756, 685, 626, 503 cm–1;1H NMR (500 MHz, CDCl3): δ 8.09–8.06 (m, 4H), 7.69- 7.66 (m, 2H), 7.47–7.44 (m, 2H), 3.37 (s, 1H), 0.15 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 183.3, 143.9 (2C), 134.4 (2C), 129.3 (2C), 128.6 (2C), 127.5 (2C), 127.3 (2C), 106.9, 91.4, 66.5, 0.32 (3C); HRMS (EI) m/z: [M + H]+ calcd for C19H18O2Si 307.1110, found 307.1152.

4.3. Procedure for Synthesis of bis-Trimethylsilylanthracen-9-one (4a/b)

A three neck RB flask (250 mL) was charged with anhydrous toluene (100 mL) and trimethylsilyl acetylene (7.4 mL, 52 mmol, 5.2 equiv). To the solution after purging with a positive pressure of argon for 30 min, n-butyllithium (2.5 M in hexane) (20.0 mL, 50 mmol) was added in a dropwise manner under argon pressure at 0 °C. The reaction mixture was allowed to attain RT under stirring condition of 45 min. Solid anthraquinone (2.08 g, 10 mmol, 1 equiv) was added to the reaction mixture in one lot. The resulting mixture was stirred for 14 h at RT. After time elapsed, the reaction was further heated at 50–55 °C for 36 h. After quenching with ammonium chloride solution under cooling and extraction with ethyl acetate, the organic phase was collected over dried Na2SO4. Concentration of organic layer under reduced pressure afforded a brown solid, where diastereoisomers 4a and 4b were isolated through silica gel (Flash) CC in ∼80% and 12% yield, respectively.

4.3.1. 9,10-bis((Trimethylsilyl)ethynyl)-9,10-dihydroanthracene-9,10-diol (4a)

White crystalline solid (3.2 g, 80% yield); mp = 155–160 °C; IR (KBr) vmax: 3316, 3068, 2959, 2355, 2159, 2127, 2030, 1733, 1663, 1604, 1450, 1400, 1248, 1196, 1045, 935, 837, 754, 627, 586, 490 cm–1;1H NMR (500 MHz, CDCl3): δ 8.15 (dd, J = 5.7, 3.3 Hz, 2H), 7.45 (dd, J = 5.7 Hz, 3.3 Hz, 2H), 3.94 (s, 1H); 0.34 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 138.4 (2C), 129.1 (2C), 127.4 (2C), 103.7, 95.4, 71.1, 0.22 (3C); HRMS (EI) m/z: [M + Na]+ calcd for C24H28O2 Si2 427.1525, found 427.1501.

4.3.2. 9,10-Dihydroxy-9,10-bis((trimethylsilyl)ethynyl)-9,10-dihydroanthracen-2-ylium (4b)

White crystalline solid (0.5 g, 12% yield); mp = 167–172 °C; IR (KBr) vmax: 3320, 3069, 2959, 2900, 2352, 2177, 2148, 2070, 1726, 1662, 1605, 1448, 1402, 1308, 1244, 1039, 973, 837, 756, 596, 495 cm–1;1H NMR (500 MHz, CDCl3): δ 7.89 (dd, J = 5.8 Hz, 3.4 Hz, 2H), 7.30 (dd, J = 5.9 Hz, 3.3 Hz, 2H), 3.00 (s, 1H), 0.01 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 138.3 (2C), 129.3 (2C), 126.8 (2C), 107.3, 92.6, 68.7, 0.20 (3C); HRMS (EI) m/z: [M + Na]+ calcd for C24H28O2 Si2 427.1525, found 427.1501.

4.4. Procedure for Synthesis of Terminal Alkyne 3

The compound 2 was dissolved in a mixture of THF:CH3OH (1:1, v/v). To the solution after purging with argon gas for 30 min, a concentrated solution of KOH was added followed by stirring for 4 h at RT. After time elapsed, extraction was carried out in ethyl acetate, and the organic phase was separated and collected over dried Na2SO4. Concentration of organic layer under reduced pressure furnished a yellowish solid, where terminal alkyne 3 was isolated in good yield by silica gel (Flash) CC.

4.4.1. 10-Ethynyl-10-hydroxyanthracen-9(10H)-one (3)

White crystalline solid (1.5 g, 78% yield); mp = 220–225 °C; IR (KBr) vmax: 3389, 3289, 2919, 2855, 2251, 2191, 2121, 2034, 1973, 1725, 1644, 1588, 1449, 1376, 1316, 1028, 922, 844, 757, 507 cm–1;1H NMR (500 MHz, CDCl3): δ 8.28–8.26 (m, 1H), 8.12- 8.10 (m, 2H), 7.78–7.77 (m, 1H), 7.71–7.68 (m, 1H), 7.53–7.49 (m, 1H), 7.43–7.41 (m, 2H), 4.12 (s, 1H), 3.02 (s, 1H); 13C NMR (125 MHz, CDCl3): δ 183.2, 143.5, 137.8, 134.2, 134.1 (2C), 133.9, 129.2, 129.1 (2C), 128.1, 127.2 (2C), 82.6, 78.0, 70.1; HRMS (EI) m/z: [M + H]+ calcd for C16H10O2 235.0714, found 235.0764.

4.5. Procedure for Synthesis of Diastereomeric Alkynes (5a/b)

The compounds 4a and 4b were solubilized separately in THF:CH3OH (1:1, v/v) in RB flasks. To the solution after purging with argon gas for 30 min, a concentrated solution of KOH was added followed by stirring for 4 h at RT. After time elapsed, the extraction of reaction mixture was done with ethyl acetate, and the organic phase was separated and collected over dried Na2SO4. Concentration of organic layer under reduced pressure furnished yellowish solid, where compounds 5a and 5b were isolated in good yield by silica gel (Flash) CC.

4.5.1. 9,10-Diethynyl-9,10-dihydroanthracene-9,10-diol (5a)

White crystalline solid (1.4 g, 67% yield); mp = 195–200 °C; IR (KBr) vmax: 3388, 3230, 2920, 2856, 2266, 2037, 1641, 1589, 1450, 1374, 1317, 1256, 1030, 923, 843, 758, 505 cm–1;1H NMR (500 MHz, CDCl3): δ 8.15 (dd, J = 5.7 Hz, 3.3 Hz, 2H), 7.46 (dd, J = 5.8 Hz, 3.3 Hz, 2H), 3.04 (s, 1H); 13C NMR (125 MHz, CDCl3): δ 137.8, 129.2, 127.2, 82.6, 78.0, 70.2; HRMS (EI) m/z: [M + Na]+ calcd for C18H12O2 283.0734, found 283.0705.

4.5.2. 9,10-Diethynyl-9,10-dihydroxy-9,10-dihydroanthracen-2-ylium (5b)

White crystalline solid (0.25 g, 77% yield); mp = 225–230 °C; IR (KBr) vmax: 3394, 3273, 3071, 2921, 2856, 2322, 2256, 2103, 2043, 1987, 1725, 1641, 1589, 1451, 1372, 1317, 1253, 1178, 1028, 973, 843, 757, 683, 501 cm–1;1H NMR (500 MHz, CDCl3): δ 8.10 (dd, J = 5.9 Hz, 3.4 Hz, 2H), 7.51 (dd, J = 5.9 Hz, 3.3 Hz, 2H), 2.80 (s, 1H); 13C NMR (125 MHz, CDCl3): δ 137.2 (2C), 129.4 (2C), 126.9 (2C), 85.9, 75.2, 67.5; HRMS (EI) m/z: [M + Na]+ calcd for C18H12O2 283.0734, found 283.0705.

4.6. General Procedure for Synthesis of Triazolyl Glycoconjugates (7)

To a round-bottom flask (50 mL) charged with anhydrous DCM (20 mL), alkyne 3 (100 mg, 0.426 mmol, 1.0 equiv), azido-sugars 6 (0.512 mmol, 1.2 equiv), CuI (40.64 mg, 0.213 mmol, 0.5 equiv), and DIPEA (0.055 mL, 0.426 mmol, 1 equiv) were added under a positive pressure of argon. The reaction mixture was stirred continuously for 12 h at RT. Concentration of reaction mixture under the reduced pressure followed by silica gel (flash) CC of the crude furnished the compounds 7a–i in good yields.

4.6.1. (2R,3R,4S,5R)-2-(4-(9-Hydroxy-10-oxo-9,10-dihydroanthracen-9-yl)-1H-1,2,3-triazol-1-yl)-2,3,4-tri-O-acetyl-β-d-xylopyranose (7a)

White crystalline solid (205 mg, 90% yield); mp = 187–192 °C; IR (KBr) vmax: 3375, 3241, 2931, 2860, 2265, 2041, 1645, 1580, 1459, 1371, 1313, 1251, 1034, 922, 849, 751, 515 cm–1;1H NMR (500 MHz, CDCl3): δ 8.06–8.01 (m, 2H), 7.66–7.62 (m, 2H), 7.46–7.44 (m, 2H), 7.43–7.41 (m, 2H), 7.39 (s, 1H), 5.72–5.68 (m, 1H), 5.35 (t, J = 9.40 Hz, 1H), 5.25–5.21 (m, 1H), 4.24–4.21 (m, 1H), 4.12 (d, J = 7.30 Hz, 1H), 3.53 (s, 1H), 2.63 (s, 1H), 2.05 (s, 3H), 2.01 (s, 3H), 1.85 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 168.8, 168.6, 168.0, 167.8, 138.2, 137.5, 136.7, 136.5, 128.1, 127.9, 127.7, 126.2, 126.0, 125.9, 125.1 (2C), 119.9, 113.0, 91.0, 85.3, 70.9, 67.3, 67.2, 21.6, 19.5, 19.1; HRMS (EI) m/z: [M + H]+ calcd for C27H25N3O9 536.1624, found 536.1646.

4.6.2. (2R,3R,4S,5R,6R)-2-(Acetoxymethyl)-6-(4-(9-hydroxy-10-oxo-9,10-dihydroanthracen-9-yl)-1H-1,2,3-triazol-1-yl)-2,3,4,6-tetra-O-acetyl-β-d-glucopyranose (7b)

White crystalline solid (207 mg, 80% yield); mp = 195–200 °C; IR (KBr) vmax: 3388, 3230, 2920, 2856, 2266, 2037, 1641, 1589, 1450, 1374, 1317, 1256, 1030, 923, 843, 758, 505 cm–1;1H NMR (500 MHz, CDCl3): δ 8.27–8.22 (m, 2H), 7.82 (d, J = 9.20 Hz, 1H), 7.76 (d, J = 10.0 Hz, 1H), 7.65–7.60 (m, 2H), 7.52–7.50 (m, 1H), 7.49 (s, 1H), 7.47–7.45 (m, 1H), 5.74 (d, J = 9.0 Hz, 1H), 5.36–5.27 (m, 2H), 5.23–5.15 (m, 1H), 4.28–4.23 (m, 1H), 4.18–4.15 (m, 1H), 4.12–4.09 (m, 1H), 3.96–3.92 (m, 1H), 2.05 (s, 3H), 2.04 (s, 3H), 1.99 (s, 3H), 1.72 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 183.2, 170.5, 169.8, 169.3, 168.7, 154.6, 145.2, 145.1, 133.9, 133.8, 130.1, 129.9, 128.8, 128.6, 127.8, 127.7, 127.2 (2C), 119.3, 85.7, 75.2, 72.3, 70.2, 69.3, 67.6, 61.4, 20.6, 20.5, 20.4, 19.9; HRMS (EI) m/z: [M + H]+ calcd for C30H29N3O11 608.1836, found 608.1810.

4.6.3. 10-Hydroxy-10-(1-((6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl)-1H-1,2,3-triazol-4-yl)-methyl-5-deoxy-2,3-O-isopropylidene-β-d-ribofuranoside (7c)

Yellow liquid (168 mg, 85% yield); IR (KBr) vmax: 3300, 3210, 2934, 2851, 2260, 2030, 1661, 1580, 1444, 1354, 1315, 1250, 1050, 929, 840, 751, 500 cm–1;1H NMR (500 MHz, CDCl3): δ 8.23 (d, J = 7.8 Hz, 2H), 7.90- 7.88 (m, 2H), 7.62 (t, J = 7.6 Hz, 2H), 7.47 (t, J = 6.9 Hz, 2H), 7.03 (s, 1H), 4.89 (s, 1H), 4.65 (d, J = 6.8 Hz, 1H), 4.55 (d, J = 5.9 Hz, 1H), 4.43–4.40 (m, 1H), 4.39–4.37 (m, 1H), 4.36 (s, 1H), 4.22–4.18 (m, 1H), 3.17 (s, 3H), 1.41 (s, 3H), 1.26 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 183.4, 153.9, 145.8 (2C), 133.9 (2C), 129.9 (2C), 128.5, 127.4 (2C), 127.1(2C), 121.1, 112.9, 110.1, 84.9, 84.7, 81.7, 72.2, 69.2, 55.5, 53.1, 26.3, 24.8; HRMS (EI) m/z: [M + H]+ calcd for C25H25N3O6 464.1777, found 464.1718.

4.6.4. (2R,3S,4S,5R,6R)-2-(Acetoxymethyl)-6-(4-(9-hydroxy-10-oxo-9,10-dihydroanthracen-9-yl)-1H-1,2,3-triazol-1-yl)-2,3,4,6-tetra-O-acetyl-β-d-galactopyranose (7d)

White crystalline solid (207 mg, 80% yield); mp = 195–200 °C; IR (KBr) vmax: 3393, 3235, 2918, 2870, 2261, 2036, 1628, 1580, 1465, 1374, 1314, 1259, 1032, 927, 849, 751 cm–1;1H NMR (500 MHz, CDCl3): δ 8.26–8.22 (m, 2H), 7.81 (d, J = 10.0 Hz, 1H), 7.75 (d, J = 10.0 Hz, 1H), 7.65–7.61 (m, 2H), 7.57 (s, 1H), 7.51–7.45 (m, 2H), 5.72 (d, J = 9.3 Hz, 1H), 5.50 (s, 1H), 5.45–5.40 (m, 1H), 5.19 (dd, J = 10.3, 3.4 Hz, 10 Hz, 1H), 4.17 (s, 1H), 4.15–4.14 (m, 1H), 4.10 (d, J = 7.2 Hz, 2H), 2.20 (s, 3H), 2.03 (s, 3H), 1.97 (s, 3H), 1.73 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 183.3, 170.3, 170.0, 169.7, 168.8, 154.5, 145.3, 145.1, 133.9, 130.0, 129.9, 128.7, 128.6, 127.1 (2C), 127.8, 127.1, 119.3, 86.2, 74.1, 70.5, 69.3, 67.8, 66.8, 61.1, 60.4, 20.7, 20.6, 20.4, 20.5; HRMS (EI) m/z: [M + H]+ calcd for C30H29N3O11 608.1836, found 608.1885.

4.6.5. 10-Hydroxy-10-(1-(((2R,3R,4S,5R,6S)-3,4,5-tris(Benzyloxy)-6-methoxytetrahydro-2H-pyran-2-yl)methyl)-1H-1,2,3-triazol-4-yl)-methyl-2,3,4-tri-O-benzyl-6-deoxy-α-d-glucopyranose (7e)

Yellow liquid (247 mg, 80% yield); IR (KBr) vmax: 3383, 3235, 2921, 2853, 2260, 2047, 1649, 1579, 1457, 1379, 1319, 1266, 1039, 921, 847, 754, 509 cm–1;1H NMR (500 MHz, CDCl3): δ 8.23 (s, 1H), 7.84 (d, J = 8.0 Hz, 2H), 7.60–7.56 (m, 2H), 7.48–7.44 (m, 4H), 7.33–7.32 (m, 4H), 7.31–7.29 (m, 8H), 7.28–7.27 (m, 3H), 6.90 (s, 1H), 4.94 (d, J = 10.8 Hz, 1H), 4.86 (d, J = 11.1 Hz, 1H), 4.76–4.69 (m, 2H), 4.61–4.56 (m, 2H), 4.45 (dd, J = 14.2 Hz, 2.4 Hz, 1H), 4.33 (d, J = 3.6 Hz, 1H), 4.07 (dd, J = 14.2, 8.0 Hz, 1H), 3.90 (t, J = 9.2 Hz, 1H), 3.69–3.64 (m, 1H), 3.32 (dd, J = 9.6 Hz, 3.6 Hz, 1H), 3.08–3.04 (m, 1H), 2.75 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 183.4, 153.7, 146.0, 145.9, 138.2, 137.7, 137.6, 133.8 (2C), 129.8, 129.7, 129.2, 129.0, 128.5 (4C), 128.4 (3C), 128.1, 128.0 (4C), 127.7, 127.3, 127.2, 127.1 (2C), 121.5, 97.7, 81.6, 79.6, 77.9, 75.7, 74.8, 73.3, 69.2, 69.0, 54.9, 50.9, 31.9, 22.6; HRMS (EI) m/z: [M + H]+ calcd for C45H43N3O6 724.2978, found 724.2982

4.6.6. (2R,3S,4S,5R,6S)-2-(Acetoxymethyl)-6-(((2R,3R,4S,5R,6R)-4,5-diacetoxy-2-(acetoxymethyl)-6-(4-(9-hydroxy-10-oxo-9,10-dihydroanthracen-9-yl)-1H-1,2,3-triazol-1-yl)4-O-(2,3,4,6-tetra-O-acetyl-β-d-galactopyranosyl)-1,2,3,6-tetra-O-acetyl-d-glucopyranose (7f)

White crystalline solid (325 mg, 85% yield); mp = 223–228 °C; IR (KBr) vmax: 3391, 3234, 2928, 2871, 2268, 2031, 1638, 1586, 1461, 1370, 1320, 1251, 1037, 922, 842, 754 cm–1;1H NMR (500 MHz, CDCl3): δ 8.30–8.25 (m, 2H), 7.85–7.83 (m, 1H), 7.79–7.75 (m, 1H), 7.67–7.61 (m, 2H), 7.53–7.46 (m, 2H), 7.36 (s, 1H), 5.70–5.64 (m, 1H), 5.39–5.32 (m, 2H), 5.26–5.22 (m, 1H), 5.21–5.16 (m, 1H), 5.12–5.08 (m, 1H), 4.97–4.94 (m, 1H), 4.50 (d, J = 7.9 Hz, 1H), 4.45–4.42 (m, 1H), 4.12–4.07 (m, 2H), 3.90–3.85 (m, 2H), 3.64–3.61 (m, 1H), 2.15 (s, 3H), 2.08 (s, 3H), 2.07 (s, 3H), 2.04 (s, 3H), 2.02 (s, 3H), 1.96 (s, 3H), 1.72 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 183.2, 170.3, 170.2, 170.1, 170.0, 169.3, 169.0, 168.9, 154.5, 145.2, 133.9, 130.1 (2C), 129.9 (2C), 128.7, 128.6, 127.7, 127.6, 127.2, 127.1, 119.2, 102.0, 101.0, 85.5, 75.9, 75.3, 72.2, 70.8, 70.5, 69.2, 69.0, 66.5, 61.7, 60.8, 20.8, 20.6 (4C), 20.5, 19.9; HRMS (EI) m/z: [M + H]+ calcd for C42H45N3O19 896.2681, found 896.2617.

4.6.7. 10-(1-(((5S,6R,6aS)-6-(Benzyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)methyl)-1H-1,2,3-triazol-4-yl)-3-O-benzyl-1,2-O-isopropylidene-α-d-xylofuranose (7g)

Yellow liquid (184 mg, 80% yield); IR (KBr) vmax: 3382, 3235, 2925, 2851, 2260, 2031, 1647, 1582, 1459, 1371, 1319, 1259, 1031, 929, 847, 759, 509 cm–1;1H NMR (500 MHz, CDCl3): δ 8.23–8.20 (m, 2H), 7.88 (d, J = 7.8 Hz, 1H), 7.85 (d, J = 7.9 Hz, 1H),7.62–7.58 (m, 2H), 7.48–7.44 (m, 2H), 7.29–7.28 (m, 3H), 7.25–7.23 (m, 2H), 7.09 (s, 1H), 5.83 (d, J = 3.7 Hz, 1H), 4.64 (d, J = 11.8 Hz, 1H), 4.55- 4.52 (m, 2H), 4.48 (d, J = 10 Hz, 1H), 4.21–4.19 (m, 1H), 4.01 (d, J = 3.2 Hz, 1H), 3.83–8.81 (m, 1H), 1.33 (s, 3H), 1.27 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 183.4, 153.6, 145.7 (2C), 137.0, 133.9, 133.8, 130.0, 129.9, 128.6 (2C), 128.5 (2C), 128.2, 127.8 (2C), 127.5, 127.4, 127.1 (2C), 122.0, 112.0, 105.1, 82.2, 81.1, 80.0, 72.2, 67.6, 53.6, 26.8, 26.2; HRMS (EI) m/z: [M + H]+ calcd for C31H29N3O6 540.2090, found 540.2134.

4.6.8. 10-Hydroxy-10-(1-((2,2,7,7-tetramethyltetrahydro-5H-bis([1,3]dioxolo)[4,5-b:4′,5′-d]pyran-5-yl)methyl)-1H-1,2,3-triazol-4-yl)-6-deoxy-1,2,3,4-di-O-isopropylidene-α-d-galactopyranose (7h)

Yellow liquid (187 mg, 85% yield); IR (KBr) vmax: 3378, 3245, 2923, 2859, 2270, 2041, 1648, 1587, 1464, 1379, 1316, 1257, 1034, 921, 849, 751, 501 cm–1;1H NMR (500 MHz, CDCl3): δ 8.23–8.21 (m, 2H), 7.86–7.82 (m, 2H), 7.62–7.58 (m, 2H), 7.48–7.44 (m, 2H), 7.25 (s, 1H), 5.37 (d, J = 4.9 Hz, 1H), 4.55 (dd, J = 7.8 Hz, 2.5 Hz, 1H), 4.45- 4.42 (m, 1H), 4.33–4.28 (m, 1H), 4.25 (dd, J = 4.9, 2.5 Hz, 1H), 4.04 (dd, J = 7.9 Hz, 1.9 Hz, 1H), 4.00–3.97 (m, 1H), 1.39 (s, 3H), 1.27 (s, 3H), 1.24 (s, 3H), 1.21 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 183.4, 153.5, 145.9, 145.8, 133.8, 133.7, 129.9 (2C), 128.4 (2C), 127.7, 127.0 (2C), 121.8, 109.8, 108.9, 96.0, 70.9, 70.6, 70.2, 69.2, 66.9, 50.5, 25.8, 25.7, 24.8, 24.2; HRMS (EI) m/z: [M + H]+ calcd for C28H29N3O7 520.2039, found 520.2094.

4.6.9. 10-(1-(2-((5S,6R,6aS)-6-(Benzyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)-2-hydroxyethyl)-1H-1,2,3-triazol-4-yl)-1H-1,2,3-triazol-1-yl)-3-O-benzyl-6-deoxy-1,2-O-isopropylidene-α-d-glucofuranose (7i)

Yellow liquid (218 mg, 90% yield); IR (KBr) vmax: 3392, 3245, 2910, 2859, 2261, 2034, 1649, 1585, 1459, 1371, 1311, 1250, 1039, 921, 849, 750, 520 cm–1;1H NMR (500 MHz, CDCl3): δ 8.22 (d, J = 9.2 Hz, 2H), 7.87–7.85 (m, 2H), 7.62 (t, J = 7.6 Hz, 2H), 7.48–7.41 (m, 4H), 7.30 (s, 1H), 7.20–7.18 (m, 2H), 7.04 (s, 1H), 6.60–6.58 (m, 1H), 5.85 (d, J = 3.8 Hz, 1H), 4.59–4.57 (m, 2H), 4.47–4.45 (m, 2H), 4.39–4.34 (m, 1H), 4.30 (d, J = 11.6 Hz, 1H), 4.12 (q, J = 7.1 Hz, 1H), 3.83 (d, J = 3.2 Hz, 1H), 3.02 (s, 1H), 1.38 (s, 3H), 1.26 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 183.4, 153.6, 145.8, 145.6, 137.9, 136.6, 133.9, 133.8 (2C), 129.9, 129.1, 128.6, 128.5 (2C), 128.2, 127.7, 127.5 (2C), 127.2, 127.1 (2C), 121.7, 112.1, 105.1, 81.8, 81.5, 78.4, 71.9, 69.2, 49.0, 26.6, 26.1; HRMS (EI) m/z: [M + H]+ calcd for C31H29N3O7 570.2196, found 570.2205.

4.7. General Method for Synthesis of bis-Triazolyl Glycoconjugates 8 and 9

Anhydrous DCM (20 mL) was added to a two neck RB flask (50 mL) charged with compound 5 (100 mg, 0.384 mmol, 1.0 equiv), azido-sugars 6 (0.9216 mmol, 2.4 equiv), CuI (73.12 mg, 0.384 mmol, 1 equiv), and DIPEA (0.134 mL, 0.768 mmol, 2 equiv) under inert argon atmosphere. The reaction mixture was stirred continuously for 24 h at RT. After 24 h elapsed, the reaction mixture was concentrated under the reduced pressure followed by silica gel (flash) CC to furnish compounds 8 and 9 in good yields.

4.7.1. (2R,3R,4S,5R)-2-(Acetoxymethyl)-6-(4-(9,10-dihydroxy-10-(1-((2R,3R,4S,5R,6R)-3,4,5-triacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)-1H-1,2,3-triazol-4-yl)-9,10-dihydroanthracen-9-yl)-1H-1,2,3-triazol-1-yl)-2,3,4,6-tetra-O-acetyl-β-d-glucopyranose (8b)

White amorphous solid (309 mg, 80% yield); mp = 210–215 °C; IR (KBr) vmax: 3390, 3289, 3231, 3069, 2922, 2857, 2372, 2190, 2118, 2035, 1985, 1738, 1642, 1589, 1450, 1371, 1317, 1217, 1034, 923, 842, 758, 686, 502 cm–1;1H NMR (500 MHz, CDCl3): δ 7.77 (s, 1H), 7.76–7.74 (m, 1H), 7.69–7.67 (m, 1H), 7.39–7.33 (m, 2H), 5.70 (d, J = 9.2 Hz, 1H), 5.49–5.43 (m, 2H), 5.19 (dd, J = 10.3 Hz, 3.3 Hz, 1H), 4.16–4.11 (m, 4H), 2.21 (s, 3H), 2.02 (s, 3H), 1.97 (s, 3H), 1.75 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 170.5, 170.1, 169.8, 168.7, 154.7, 138.7, 138.1, 128.5, 128.6, 128.4, 127.3, 120.6, 86.0, 73.7, 70.7, 69.4, 69.1, 66.8, 61.1, 20.6, 20.6, 20.4, 20.1; HRMS (EI) m/z: [M + H]+ calcd for C46H50N6O2 1007.3113, found 1007.3111.

4.7.2. 9,10-bis(1-((6-Methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl)-1H-1,2,3-triazol-4-yl)-methyl-5-deoxy-2,3-O-isopropylidene-β-d-ribofuranoside (8c)

Yellow liquid (250 mg, 85% yield); mp = 210–215 °C; IR (KBr) vmax: 3370, 3281, 3239, 3054, 2920, 2851, 2370, 2199, 2120, 2040, 1990, 1739, 1644, 1595, 1459, 1376, 1315, 1227, 1036, 900, 840, 759, 680, 501 cm–1;1H NMR (500 MHz, CDCl3): δ 7.91–7.87 (m, 2H), 7.42–7.40 (m, 2H), 7.07 (s, 1H), 5.85–5.79 (m, 1H), 4.89 (s, 1H), 4.61 (d, J = 6.9 Hz, 1H), 4.56 (d, J = 5.9 Hz, 1H), 4.25–4.21 (m, 1H), 4.14–4.10 (m, 1H), 3.17 (s, 3H), 1.42 (s, 3H), 1.27 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 153.4, 138.7.1, 138.6, 128.4, 128.4, 126.7, 126.6, 122.8, 112.8, 110.0, 84.9, 84.8, 81.7, 69.3, 55.5, 52.8, 26.3, 22.8; HRMS (EI) m/z: [M + H]+ calcd for C36H42 N6O10 719.2996, found 719.3045.

4.7.3. (2R,3R,4S,5R)-2-(Acetoxymethyl)-6-(4-(9,10-dihydroxy-10-(1-((2R,3R,4S,5R,6R)-3,4,5-triacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)-1H-1,2,3-triazol-4-yl)-9,10-dihydroanthracen-9-yl)-1H-1,2,3-triazol-1-yl)-2,3,4,6-tetra-O-acetyl-β-d-galactopyranose (8d)

White amorphous solid (309 mg, 80% yield); mp = 208–213 °C; IR (KBr) vmax: 3385, 3280, 3200, 3065, 2911, 2840, 2366, 2170, 2113, 2021, 1970, 1722, 1631, 1585, 1442, 1374, 1315, 1210, 1028, 920, 835, 750, 680, 500 cm–1;1H NMR (500 MHz, CDCl3): δ 7.79 (s, 1H), 7.74–7.72 (m, 1H), 7.67–7.65 (m, 1H), 7.37–7.31 (m, 2H), 5.70 (d, J = 9.3 Hz, 1H), 5.47–5.43 (m, 2H), 5.18 (dd, J = 10.3 Hz, 3.4 Hz, 1H), 4.56 (s, 1H), 4.15–4.10 (m, 4H), 2.21 (s, 3H), 2.01 (s, 3H), 1.96 (s, 3H), 1.72 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 170.5, 170.1, 169.8, 168.7, 154.8, 138.7, 138.1, 128.5, 128.3, 127.3 (2H), 120.7, 85.9, 73.6, 70.7, 69.4, 68.0, 66.8, 61.1, 20.6, 20.6, 20.4, 20.0; HRMS (EI) m/z: [M + H]+ calcd for C46H50N6O2 1007.3113, found 1007.3111.

4.7.4. (2R,3R,4S,5R)-2-(Acetoxymethyl)-6-(4-(9,10-dihydroxy-10-(1-((2S,3S,4R,5S,6S)-3,4,5-triacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)-1H-1,2,3-triazol-4-yl)-9,10-dihydroanthracen-9-yl)-1H-1,2,3-triazol-1-yl)-2,3,4,6-tetra-O-acetyl-β-d-galactopyranose (9)

White amorphous solid (335 mg, 86% yield); mp = 212–217 °C; IR (KBr) vmax: 3390, 3289, 3231, 3069, 2922, 2857, 2372, 2190, 2118, 2035, 1985, 1738, 1642, 1589, 1450, 1371, 1317, 1217, 1034, 923, 842, 758, 686, 502 cm–1;1H NMR (500 MHz, CDCl3): δ 8.29 (s, 1H), 7.42–7.40 (m, 1H), 7.36–7.34 (m, 1H), 7.27–7.25 (m, 1H), 7.24–7.22 (m, 1H), 5.82 (d, J = 9.2 Hz, 1H), 5.64–5.60 (m, 1H), 5.55 (s, 1H), 5.36 (s, 1H), 5.25 (dd, J = 10.3 Hz, 3.4 Hz, 1H), 4.24–4.20 (m, 2H), 4.18–4.15 (m, 1H), 2.26 (s, 3H), 2.05 (s, 3H), 2.01 (s, 3H), 1.79 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 170.4, 170.1, 169.9, 168.9, 155.2, 139.9, 139.8, 128.5, 128.4, 127.2 (2H), 119.9, 86.4, 74.0, 71.0, 70.7, 68.1, 66.9, 61.3, 20.7, 20.6, 20.5, 20.1; HRMS (EI) m/z: [M + H]+ calcd for C46H50N6O2 1007.3113, found 1007.3111.

4.8. Procedure for Deprotection of Acetyl-Protected Glycohybrid Triazole 9

To a RB flask charged with compound 9, a mixture of anhydrous DCM-MeOH (1:1, v/v) and 1.0 mL NaOMe solution (0.5 M) was added.23 After 24 h stirring at RT, the reaction mixture was concentrated under reduced pressure to afford a crude which was further purified by CC to obtain compound 10 in 90% yield.

4.8.1. 6,6′-((9,10-Dihydroxy-9,10-dihydroanthracene-9,10-diyl)bis(1H-1,2,3-triazole-4,1-diyl))bis(2-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol) (10)

White crystalline solid (60 mg, 90% yield); 1H NMR (500 MHz, DMSO-d6): δ 8.50 (s, 1H), 8.38 (s, 1H), 7.36 (dd, J = 5.9, 3.4 Hz, 1H), 7.32 (dd, J = 5.9, 3.4 Hz, 1H), 7.27 (dd, J = 6.5, 3.0 Hz, 2H), 5.49 (d, J = 9.1 Hz, 1H), 4.85 (s, 1H), 4.09 (t, J = 9.3 Hz, 2H), 3.78 (d, J = 3.2 Hz, 2H), 3.72 (t, J = 6.2 Hz, 2H), 3.57–3.54 (m, 2H), 3.54–3.51 (m, 1H); 13C NMR (125 MHz, DMSO-d6): δ 166.0, 153.8, 140.8, 140.8, 127.5, 126.9, 126.8, 121.3, 88.2, 78.5, 73.6, 70.4, 69.4, 68.3, 60.3.

4.9. Procedure for Deprotection of Isopropylidene-Protected Glycohybrid Triazole 7h

The isopropylidene-protected anthraquinone glycohybrid triazole 7h was successfully deprotected by treatment with a mixture of trifluoroacetic acid (TFA) and water in a RB flask for 3h at RT.19

4.9.1. 10-Hydroxy-10-(1-((3,4,5,6-tetrahydroxytetrahydro-2H-pyran-2-yl)methyl)-1H-1,2,3-triazol-4-yl)-α-d-galactopyranose (11)

White amorphous solid (105 mg, 70% yield); mp = 180–185 °C; IR (KBr) vmax: 3410, 3310, 3060, 2947, 2835, 2380, 2191, 2101, 2039, 1971, 1647, 1580, 1433, 1375, 1318, 1248, 1031, 935, 851, 766, 689, 501 cm–1;1H NMR (500 MHz, DMSO-d6): δ 8.04 (d, J = 7.8 Hz, 2H), 7.96 (s, 1H), 7.75–7.73 (m, 2H), 7.64–7.60 (m, 2H), 7.46–7.43 (m, 2H), 6.94 (s, 1H), 6.15 (d, J = 5.0 Hz, 1H), 4.84–4.82 (m, 1H), 4.69–4.67 (m, 1H), 4.66–4.64 (m, 1H), 4.53 (d, J = 5.0 Hz, 1H), 4.33–4.27 (m, 2H), 4.14–4.10 (m, 1H), 3.78–3.75 (m, 1H), 3.54 (s, 1H), 3.50–3.45 (m, 1H); 13C NMR (125 MHz, DMSO-d6): δ 183.2, 153.8, 153.7, 147.5, 133.6, 129.6, 127.9, 127.6 (2C), 125.8, 121.9, 121.8, 97.2, 92.5, 72.8, 72.5, 71.5, 69.3, 68.8, 68.6, 68.2, 50.7; HRMS (EI) m/z: [M + H]+ calcd for C22H21N3O7 440.1413, found 440.1410.

Acknowledgments

The research facilities of DBT-Center of Innovative and Applied Bioprocessing (CIAB) and SAIF Panjab University, Chandigarh are acknowledged.

Supporting Information Available

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsomega.2c02938.

  • Analytical data (1H NMR, 13C NMR, and HR-MS), single-crystal structures, and crystallographic refinement data of compounds (PDF)

  • Compounds 2, 3, 4a, 5a, and 7a (ZIP)

The authors declare no competing financial interest.

Supplementary Material

ao2c02938_si_001.pdf (5.1MB, pdf)
ao2c02938_si_002.zip (534.3KB, zip)

References

  1. Malik M. S.; Alsantali R. I.; Jassas R. S.; Alsimaree A. A.; Syed R.; Alsharif M. A.; Kalpana K.; Morad M.; Althagafi I. I.; Ahmed S. A. Journey of anthraquinones as anticancer agents- a systematic review of recent literature. RSC Adv. 2021, 11, 35806. 10.1039/D1RA05686G. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Monks T. J.; Hanzlik R. P.; Cohen G. M.; Ross D.; Graham D. G. Quinone chemistry and toxicity. Toxicol. Appl. Pharmacol. 1992, 112, 2–16. 10.1016/0041-008X(92)90273-U. [DOI] [PubMed] [Google Scholar]
  3. Gaginella T. S.; Bass P. Laxatives: an update on mechanism of action. Life Sci. 1978, 23, 1001–1010. 10.1016/0024-3205(78)90659-8. [DOI] [PubMed] [Google Scholar]
  4. Zargar B. A.; Masoodi M. H.; Ahmed B.; Ganie S. A. Phytoconstituents and therapeutic uses of Rheum emodi wall. ex Meissn. Food Chem. 2011, 128, 585–589. 10.1016/j.foodchem.2011.03.083. [DOI] [Google Scholar]
  5. Tian W.; Wang C.; Li D.; Hou H. Novel anthraquinone compounds as anticancer agents and their potential mechanism. Future Med. Chem. 2020, 12, 627–644. 10.4155/fmc-2019-0322. [DOI] [PubMed] [Google Scholar]
  6. Van Gorkom B. A.; de Vries E. G.; Karrenbeld A.; Kleibeuker J. H. Review article: Anthranoid laxatives and their potential carcinogenic effects. Aliment Pharmacol Ther. 1999, 13, 443–452. 10.1046/j.1365-2036.1999.00468.x. [DOI] [PubMed] [Google Scholar]
  7. Shrestha J. P.; Fosso M. Y.; Bearss J.; Chang C-WT. Synthesis and anticancer structure activity relationship investigation of cationic anthraquinone analogs. Eur. J. Med. Chem. 2014, 77, 96–102. 10.1016/j.ejmech.2014.02.060. [DOI] [PubMed] [Google Scholar]
  8. Shrestha J. P.; Subedi Y. P.; Chen L.; Chang C-WT. A mode of action study of cationic anthraquinone analogs: A new class of highly potent anticancer agents. MedChemComm. 2015, 6, 2012–2022. 10.1039/C5MD00314H. [DOI] [Google Scholar]
  9. Khan N.; Karodi R.; Siddiqui A.; Thube S.; Rub R. Development of anti-acne gel formulation of anthraquinones rich fraction from Rubia cordifolia (Rubiaceae). Int. J. Appl. Res. Nat. Prod. 2011, 4, 28–36. [Google Scholar]
  10. Fosso M. Y.; Chan K. Y.; Gregory R.; Chang C-WT. Library synthesis and antibacterial investigation of cationic anthraquinone analogs. ACS Comb Sci. 2012, 14, 231–235. 10.1021/co2002075. [DOI] [PubMed] [Google Scholar]
  11. Sakulpanich A.; Gritsanapan W. Determination of anthraquinone contents in Cassia fistula leaves for alternative source of laxative drugs. Planta Med. 2009, 75, 994. 10.1055/s-0029-1234665. [DOI] [Google Scholar]
  12. Yu B.; Sun J.; Yang X. Assembly of naturally occurring glycosides, evolved tactics, and glycosylation methods. Acc. Chem. Res. 2012, 45, 1227–36. 10.1021/ar200296m. [DOI] [PubMed] [Google Scholar]
  13. Agrahari A. K.; Bose P.; Jaiswal M. K.; Rajkhowa S.; Singh A. S.; Hotha S.; Mishra N.; Tiwari V. K. Cu(I)-Catalyzed click chemistry in glycoscience and their diverse applications. Chem. Rev. 2021, 121, 7638–7956. 10.1021/acs.chemrev.0c00920. [DOI] [PubMed] [Google Scholar]
  14. Pandey N.; Jyoti; Singh M.; Dwivedi P.; Sahoo S. C.; Mishra B. B. Click chemistry inspired synthesis of andrographolide triazolyl conjugates for effective fluorescent sensing of ferric ions. Nat. Pro Res. 2021, 14, 1–11. 10.1080/14786419.2021.2013837. [DOI] [PubMed] [Google Scholar]
  15. Zhu Y.; Pi J.; Zhang Y.; Xu D.; Yagci Y.; Liu R. New anthraquinone derivative as a near UV and visible light photoinitiator for free-radical, thiol-ene and cationic polymerizations. Polym. Chem. 2021, 12, 3299–3306. 10.1039/D1PY00347J. [DOI] [Google Scholar]
  16. Hou L.; Kong X.; Wang Y.; Chao J.; Li C.; Dong C.; Wang Y.; Shuang S. An anthraquinone-based highly selective colorimetric and fluorometric sensor for sequential detection of Cu2+ and S2- with intracellular application. J. Mater. Chem. B 2017, 5, 8957–8966. 10.1039/C7TB01596H. [DOI] [PubMed] [Google Scholar]
  17. Taylor M. S.; Swager T. M. Triptycenediols by Rhodium-Catalyzed [2 + 2+2] Cycloaddition. Org. Lett. 2007, 9, 3695–3697. 10.1021/ol701642j. [DOI] [PubMed] [Google Scholar]
  18. Kumar D.; Mishra K. B.; Mishra B. B.; Mondal S.; Tiwari V. K. Click chemistry inspired highly facile synthesis of triazolyl ethisterone glycoconjugates. Steroids. 2014, 80, 71–79. 10.1016/j.steroids.2013.11.022. [DOI] [PubMed] [Google Scholar]
  19. Dwivedi P.; Mishra K. B.; Mishra B. B.; Singh N.; Singh R. K.; Tiwari V. K. Click inspired synthesis of triazole-linked vanillin glycoconjugates. Glycoconj J. 2015, 32, 127–140. 10.1007/s10719-015-9582-x. [DOI] [PubMed] [Google Scholar]
  20. Laxmi Madhavi N. N.; Bilton C.; Howard J. A. K.; Allen F. H.; Nangia A.; Desiraju G. R. Seeking structural repetitivity in systems with interaction interference: crystal engineering in the gem-alkynol family. New J. Chem. 2000, 24, 1–4. 10.1039/a908233f. [DOI] [Google Scholar]
  21. Mondal R.; Howard J.; Banerjee R.; Desiraju G. Crystallographic studies of supramolecular synthons in amine solvates of trans-1,5-dichloro-9,10-diethynyl-9,10- dihydroanthracene-9,10-diol. Cryst. Growth Des. 2006, 6, 2507–2516. 10.1021/cg060258m. [DOI] [Google Scholar]
  22. VanVeller B.; Robinson D.; Swager T. M. Triptycene Diols: A strategy for synthesizing planar π systems through catalytic conversion of a poly(p-phenylene ethynylene) into a poly(p-phenylene vinylene). Angew. Chem., Int. Ed. 2012, 51, 1182–1186. 10.1002/anie.201106985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Bonner W. A.; Koehler W. L. The deacetylation of acetylated carbohydrate derivatives with potassium alkoxides. J. Am. Chem. Soc. 1948, 70, 314–316. 10.1021/ja01181a096. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ao2c02938_si_001.pdf (5.1MB, pdf)
ao2c02938_si_002.zip (534.3KB, zip)

Articles from ACS Omega are provided here courtesy of American Chemical Society

RESOURCES